OMCL Stock Price, Chart, Stats & News

Omnicell, Inc.
Save
1.75B
Market cap
87.30x
Current P/E
29.50x
Forward P/E
OMCL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 42.49% |
Operating margin | 0.44% |
Pretax margin | 0.96% |
Net margin | 0.17% |
Effective tax rate | 81.88% |
ROA | 0.10% |
ROE | 0.17% |
D/E | 0.17x |
Interest coverage ratio | 2.12x |
OMCL valuation
P/E | 87.30x |
P/S | 1.26x |
P/B | 1.20x |
P/CF | 11.57x |
P/FCF | 17.62x |
P/OCF | 11.57x |
PEG | -8.01x |
EV multiple | 16.16x |
About
Omnicell, Inc., founded in 1992 and headquartered in Mountain View, California (initially operating as Omnicell Technologies, Inc. until its name change in 2001), delivers advanced medication management technologies and patient adherence solutions. The company serves healthcare systems and pharmacies both domestically within the United States and globally. Its extensive portfolio of offerings includes: Clinical Workflow Automation: Omnicell provides automated solutions designed to streamline clinician tasks in patient care environments.
Similar securities
Based on sector and market capitalization
Report issue











